Tag: Motley Fool

The Charter Hall Group (ASX: CHC) share price is on watch this morning after the property business announced 14% growth of its funds under management to $46.4 billion.

In early trading the Charter Hall share price has fallen 5% in response to the report. 

If you haven’t heard of Charter Hall, it’s a diversified property business that owns and also manages a large property portfolio on behalf of shareholders various property funds including Charter Hall Long WALE REIT (ASX: CLW).

Charter Hall’s FY21 half-year result

The company reported that it generated $129 million of operating earnings, equating to operating earnings per share (EPS) of 27.8 cents. It generated $173 million of statutory profit.

Charter Hall managing director David Harrison said: “Notwithstanding the challenges presented by COVID-19, we have been well insulated by our on-going focus on long WALE properties leased to high quality tenants. As a result, we continue to enjoy the support of our investors who remain keen to invest alongside us in Australian commercial real estate.”

Property investment

Charter Hall runs its own property investment portfolio worth $2 billion. This portfolio generated a total property investment return of 10.9% for the period.

Management said that the earnings resilience and diversification of the property investment portfolio continues to remain a key strength, with the top 10 asset exposures representing only 10.4% of earnings and the portfolio is 80% weighted towards the Australian East Coast market. Portfolio occupancy was 97.1% and the weighted average lease expiry (WALE) improved from 8.7 years to 9.1 years.

The property investment yield was 6% for the half-year.

Property funds management

Charter Hall said that its fund management portfolio is now 8.5 million sqm in size, diversified across five sectors. The funds under management (FUM) grew by 14% to $46.4 billion, driven by $3.5 billion of net acquisitions (and $6.2 billion gross transactions), positive property revaluations of $1.1 billion and capital expenditure on developments of $1.2 billion.

The property business announced that it experienced $2.8 billion of gross equity allotment, comprising $766 million in wholesale pooled funds, $1.1 billion in wholesale partnerships, $392 million allotted in listed funds and $520 million in direct funds.

Management said it still had $6.4 billion of investment capacity to keep growing.

The property funds management yield was 4.8%, according to Charter Hall.

Balance sheet

A key focus of the business is capital management with $3.7 billion of new and refinanced facilities during the period and no material maturities in FY21 or FY22. Charter Hall said that it maintains financial flexibility and substantial funding capacity.

The weighted average gearing across the fund platform was 28%, which Charter Hall said was conservative.

Charter Hall distribution and outlook

Charter Hall reminded investors that the distribution for this result was 18.6 cents per security, representing growth of around 6%. The FY21 distribution is still expected to grow by 6% compared to FY20.

The group’s previous FY21 guidance was for post-tax operating EPS (OEPS) of approximately 53 cents per security. Assuming no material changes in the market conditions and the COVID-19 operating environment doesn’t significantly worsen, the FY21 guidance for OEPS is no less than 55 cents, excluding any accrued performance fees, which would represent a slight increase in underlying operating earnings.

More reading

• 2 ASX shares rated as buys by brokers
• 2 ASX shares rated as strong buys by brokers

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Charter Hall (ASX:CHC) share price down 5% after 14% growth in HY21 result appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3aqV5DS

In morning trade the Domino’s Pizza Enterprises Ltd (ASX: DMP) share price is pushing higher following the release of its half year results.

At the time of writing, the pizza chain operator’s shares are up 2% to $99.72.

How did Domino’s perform in the first half?

Domino’s was a very positive performer during the first half of FY 2021, delivering strong sales growth and even stronger earnings growth.

For the six months ended 31 December, Domino’s delivered total global food sales of $1.84 billion. This was an increase of $260.8 million or 16.5% over the prior corresponding period.

This strong top line growth was driven by same store sales growth of 8.5% and the opening of 131 organic new stores. The majority of its new store openings were in Japan, with 68 new stores. This was supported by 50 new stores Europe and 13 new stores in the ANZ market.

Thanks to margin expansion, Domino’s earnings before interest and tax (EBIT) grew at the even quicker rate of 32.3% to $153 million.

This was predominantly driven by its international operations, which delivered EBIT growth of 55.7% to $99.9 million. Its international operations now account for 65.3% of total EBIT. ANZ EBIT grew 9.8% to $63.7 million.

On the bottom line, the company’s underlying net profit after tax increased 32.8% to $96.2 million.

Also growing strongly was the pizza chain operator’s free cash flow. It came in 50.3% higher at $124.4 million.

This allowed the Domino’s board to declare an interim dividend of 88.4 cents per share (50% franked). This represents an increase of 32.5% over last year’s dividend.

Management commentary

Domino’s CEO and Managing Director, Don Meij, was very pleased with the company’s performance. He believes the result reflects experienced management and franchisees executing on a long-term strategy, rather than one-off costs or short-term sales attributable to COVID-19.

He said: “The performance this half predominantly reflects the benefits from investing in, and strengthening, our franchisee base and expanding our store footprint on a global scale, and the efforts of tens of thousands of our people executing against our strategy.”

“Despite the unique challenges of this time, store openings have accelerated with an average of five new stores opening each week, which reflects the confidence Domino’s, and our franchisees, share in our future. We intend to significantly outperform this strong result in the Second Half.”

Outlook

As Mr Meij stated above, Domino’s intends to “significantly outperform” its strong first half result in the second half.

And the company certainly is on course to do this, with total network sales growing 20.9% during the first seven weeks of the second half. This has been driven by same stores sales growth of 10.1% over the period. Management also revealed that it has already opened 11 new stores since the end of the first half.

Mr Meij commented: “We continue to experience uncertain times, but have confidence the clear principles that have delivered Domino’s success, before and during COVID-19, will guide this next phase.”

“Our team’s agile response to changing conditions has lifted our expectations for Full Year performance to be even higher than our already positive, medium-term outlook. With a strong balance sheet and franchisee profitability, we intend to accelerate expansion,” he concluded.

More reading

• Top brokers name 3 ASX shares to sell today
• Why CIMIC, Crown, Domino’s, & Praemium shares are tumbling lower today
• Leading broker tips 3 ASX shares to positively surprise during earnings season
• What analysts expect from the Domino’s (ASX:DMP) first half result
• 2 quality ASX growth shares that could be long term market beaters

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Domino’s (ASX:DMP) share price higher after delivering strong first half growth appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3b6ZkU8

The Corporate Travel Management Ltd (ASX: CTD) share price is under pressure on Tuesday following the release of its half year results.

At the time of writing, the corporate travel specialist’s shares are down almost 2% to $17.71.

How did Corporate Travel Management perform in the first half?

Corporate Travel Management had a tough half due to the impact that COVID-19 has had on global travel markets.

For the six months ended 31 December, the company reported an 88% decline in total transaction value (TTV) to $403.8 million. This led to a 75% reduction in half year revenue (excluding government grants and other income) to $56.5 million.

Including government grants of $13.7 million and other income of $4 million, revenue was down 67% to $74.25 million.

On the bottom line, the company reported an underlying loss after tax of $26 million and a statutory loss after tax of $36.4 million. The latter compares to a pre-COVID profit of $32.9 million in the prior corresponding period.

At the end of the period, Corporate Travel Management had net cash of $119 million. This had reduced slightly to $115 million as of 15 February. The company also has a $178 million undrawn committed finance facility.

Unsurprisingly, the Corporate Travel Management board will not be declaring an interim dividend.

Management commentary

The company’s Managing Director, Jamie Pherous, remains positive on the future and notes that its operations are close to becoming break-even.

He said: “We are in a good position to capitalise on a recovery in corporate travel activity because we have a strong balance sheet with excess cash for further opportunities. We are now very close to a break-even position with new client revenue momentum and remain most leveraged to the largest travel markets that are also the most advanced in rolling out vaccinations.”

Mr Pherous also appears confident that the company will come out of the crisis in a stronger position. This is especially the case following its T&T acquisition and new client wins.

He explained: “We are positioned to be a significantly larger business post-COVID due to the strategic acquisition of T&T, the organic growth dynamics we are experiencing and a lower permanent cost base. Significant new client wins across all of our regions supported a better than expected first-half earnings result and have given us revenue momentum into the second half.”

“We have maintained service levels throughout the pandemic and continued to invest in our proprietary technology to deploy tailored solutions to quickly address changing client needs. In fact, technology spend is returning to pre-COVID levels. Our scale and financial strength, combined with CTM’s personalised service and tailored technology solutions, have translated into new client wins and growing market share globally,” he added.

Outlook

Given the continuing uncertainty regarding government travel restrictions and the efficacy of national vaccination programs, management advised that it is not in a position to provide earnings guidance for the second half.

However, it does expect its ANZ and European operations to be profitable during the half. This is thanks to vaccine rollouts, a lower permanent cost base, and ANZ domestic borders remaining largely open.

Mr Pherous concluded: “Whilst Australia and New Zealand have not commenced their vaccination programmes, USA and UK are well advanced. The UK (population 67m) has surpassed 15m vaccinations and the USA (population 329m) has surpassed 50m vaccinations. Both countries expect to have the high-risk segment of the population vaccinated in this quarter, potentially allowing a relaxation in travel restrictions, much earlier than ANZ. Given 70% of our pre-COVID revenue is derived from the UK and USA, we are well positioned for the incremental revenue gains from travel relaxations in these markets.”

More reading

• 2 ASX shares brokers expect to fly higher
• Why ASX travel shares were smashed on Friday
• ASX 200 Weekly Wrap: ASX cools on earnings reality check
• Here’s a bargain ASX share in a sea of expensive stocks
• Top brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Corporate Travel Management (ASX:CTD) share price is trading lower appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/37lLWdJ

ASX mid-cap healthcare company Avita Medical Inc (ASX: AVH) released its second-quarter FY21 results to the market last week. Despite recording positive revenue numbers, the Avita share price has continued to slide lower over the last five days. At their current price of $6.40, Avita shares are now more than 30% below their 52-week high price of $9.58.

What does Avita do?

Avita is one of a number of biotech companies currently trading on the ASX specialising in skin tissue repair, particularly relating to serious burns or other traumatic injuries. Its competitors in this space include Polynovo Ltd (ASX: PNV) and New Zealand-based Aroa Biosurgery Ltd (ASX: ARX).

Avita’s flagship technology, its RECELL System, uses a sample of the patient’s own skin to create “spray-on skin cells” which can then be applied to wounds or other affected areas on the patient’s body. The company claims its technology harnesses the skin’s own regenerative properties to help heal severe wounds.

What was in the company’s results?

Avita reported a 57% year-on-year jump in revenues to $5.1 million for the December quarter. However, it’s worth noting that this result was actually flat against the previous quarter, ended 30 September 2020. Procedural volumes for the December quarter were also slightly lower than the prior quarter.

The company’s inability to provide any firm earnings guidance for the remainder of FY21 may have also scared away some investors, driving the Avita share price lower. Avita revealed that nearly half of its revenues came from just 20 accounts, all of which are exposed to the effects of COVID-19.

How does Avita stack up against its competitors?

Avita’s December quarter results were actually surprisingly similar to those of Aroa Biosurgery. Aroa, whose flagship product is a biodegradable tissue repair device originally derived from a sheep’s forestomach, reported revenues of NZ$5.9 million for the December quarter.

This is also similar to Polynovo. In a first-half trading update released to the market in January, Polynovo stated that sales revenues were up 31% versus the first half of FY20, despite slow months in November and December. This would imply first-half sales of a little over $11 million (1H FY20 sales revenue was $8.57 million), or about $5.5 million on an average quarterly basis. Again, this puts it roughly in line with both Aroa and Avita.

All three companies are also trying to expand their global footprint. Avita recently redomiciled to the United States, as this is where it generates the overwhelming majority of its revenues ($5 million of its $5.1 million December quarter revenues came from the US market).

Polynovo has been expanding rapidly into new European markets, most recently Poland and Turkey, and already has a presence in the US and Taiwan. And Aroa has recently received regulatory approvals to start distributing its products in India.

At the moment, it’s difficult to tell which of these companies will end up on top. The next 12 months may be a crucial period for Avita, Polynovo and Aroa. It will be interesting to see whether all three companies can deliver on their competing growth strategies.

More reading

• These are the 10 most shorted shares on the ASX
• A turbulent tale of 2 ASX biotech shares: Polynovo (ASX:PNV) and Pro Medicus (ASX:PME)
• Why AVITA, Baby Bunting, Kathmandu, & Webjet shares are sinking
• The AVITA Medical (ASX: AVH) share price plummets almost 6% in early trade
• Here are the 10 most shorted shares on the ASX

Rhys Brock owns shares of Avita Medical Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Avita Medical Limited and POLYNOVO FPO. The Motley Fool Australia has recommended Avita Medical Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post How do Avita Medical (ASX:AVH) shares stack up against Polynovo and Aroa Biosurgery? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/37lJeF5

The HomeCo Daily Needs REIT (ASX: HDN) share price is one to watch in early trade today. Shares in the Aussie real esate investment trust (REIT) are worth watching after a half-year results update and FY21 guidance upgrade.

Why is the HomeCo share price on watch?

The HomeCo Daily Needs REIT primarily invests in metro-located, convenience-based assets across neighbourhood retail, large format retail, and health & services.

The HomeCo share price is on watch this morning after the REIT released its interim report for the period ended 31 December 2020 (1H 2021).

HomeCo reported 98.7% occupancy across its portfolio, up 0.2% from October 2020. Supermarket moving annual turnover (MAT) jumped 22% with 2 supermarkets moved to turnover rent.

Annual foot traffic increased 19% on a like for like basis in the December 2020 quarter versus December 2019.

On the financial side, cash collections totalled 99% for November 2020 to January 2021 since the HomeCo REIT’s IPO.

HomeCo has now completed $104 million of acquisitions since IPO which is driving valuation and funds from operations (FFO) growth.

The Aussie REIT reported $3.1 million in FFO from the 23 November IPO to 31 December 2020. That figure came from total revenue of $6.8 million with operating earnings before interest, tax, depreciation and amortisation (EBITDA) totalling $4.1 million.

What about the updated earnings?

It’s not just the half-year update that could move the HomeCo share price in early trade. The Aussie REIT also provided updated earnings guidance for FY2021 alongside this morning’s announcement.

HomeCo upgraded FY2021 (FFO) guidance to 4.2 cents per unit this morning. That reflects a 9% increase to the PDS FY2021 FFO guidance and is the second such upgrade since the group’s November IPO.

The HomeCo share price is on watch after also upgrading net tangible assets to $1.34 per unit compared to $1.33 PDS guidance.

Foolish takeaway

Today’s half-year earnings result was limited, given it only accounted for ~40 days of operations since the REIT’s November 2020 IPO.

However, the HomeCo Daily Needs share price is one to watch after updated earnings guidance for FY2021 announced this morning.

More reading

• Leading broker says Redbubble (ASX:RBL) share price selloff is a buying opportunity
• Westpac (ASX:WBC) share price on watch as it delivers $2bn quarterly profit result
• EBOS (ASX:EBO) share price on watch after dividend surge
• Coles (ASX:COL) share price on watch following half year update
• Why the Hub24 (ASX:HUB) share price will be on watch today

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the HomeCo (ASX:HDN) share price is one to watch appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3aoJOUk

On Tuesday the Redbubble Ltd (ASX: RBL) share price was among the worst performers on the Australian share market.

The ecommerce company’s shares crashed 18% lower to $5.67.

Why did the Redbubble share price crash lower?

Investors were selling Redbubble shares following the release of its half year results.

For the six months ended 31 December, Redbubble reported a 96% increase in marketplace revenue to $352.8 million and a 118% lift in gross profit to $144 million.

This ultimately led to the company posting earnings before interest and tax (EBIT) of $41.8 million, which was up from a loss of $1.9 million in the prior corresponding period.

While this is of course meteoric growth, it fell short of the market’s expectations due to weaker than expected gross margins and higher customer acquisition costs.

Goldman Sachs commented: “RBL has released its 1H21 result which beat our forecasts on revenues but missed on costs (lower Gross Margin and higher paid acquisition).”

The broker notes that gross margins fell from 43.7% in the first quarter to 38.7% in the second. Whereas customer acquisition costs as a percentage of revenue rose from 10.2% in the first quarter to 14.2% in the second quarter.

Is this a buying opportunity?

Although Goldman was disappointed with many aspects of its result, it sees the weakness in the Redbubble share price as a buying opportunity. Especially given how its investment thesis remains unchanged.

It explained: “While this was disappointing, our investment thesis remains unchanged: large global addressable market, e-Commerce trends that should be broadly supportive of online demand remaining robust, a strong balance sheet (net cash > A$120m by end of FY21E) and a new CEO who we believe could focus the business more sharply on driving new customer growth, improving repeat transactions, accelerating product roll-outs and investment in data analytics, in line with the company’s stated focus areas.”

In addition, the broker believes the Redbubble share price is attractive relative to its peer group.

As a result, Goldman Sachs has put a buy rating and $7.15 price target on its shares.

Based on the latest Redbubble share price, this price target implies potential upside of almost 26% over the next 12 months.

More reading

• 3 things you might have missed from the Redbubble (ASX:RBL) result
• ASX 200 rises 0.7%, Redbubble sinks, BHP dividend jumps
• Why ARB, Domain, Redbubble, & Treasury Wine shares are sinking today
• Redbubble (ASX:RBL) share price sinks 13% despite strong H1 FY21 results
• Got money to invest? Here are 3 ASX shares to buy

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Leading broker says Redbubble (ASX:RBL) share price selloff is a buying opportunity appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2NvL92X

The Westpac Banking Corp (ASX: WBC) share price will be in the spotlight this morning after it posted a $1.97 billion quarterly cash profit.

The big bank’s result reaffirms the recovery in the sector as the December quarter profit was up on the 2HFY20 quarterly average of $808 million.

Westpac’s statutory net profit was also sharply higher at $1.7 billion compared to the average $550 million in its second half.

The real highlight in Westpac’s results

But Westpac managed to do something its peers have so far been unable to – that is to lift profit margin!

The bank’s net interest margin (the difference between the cost of debt and how much the bank can charge for loans) expanded 3 basis points (bps) to 2.06%.

The NIM for Commonwealth Bank of Australia (ASX: CBA) and National Australia Bank Ltd. (ASX: NAB) fell in their latest earnings reports. Australia and New Zealand Banking GrpLtd (ASX: ANZ) has yet to release its update and is the last of the big four to do so.

Westpac pulls on growth levers

Coming back to Westpac’s profit recovery, it’s not only margins that is driving earnings. The bank recorded an impairment benefit of $501 million in the period as the COVID-19 shock receded.

ASX banks were forced to squirrel away extra cash to buffer from the possibility of widespread loan defaults due to the pandemic.

The economic impact of COVID weren’t as severe as originally feared and every dollar that the banks release from provisions and impairments will flow straight back to the bottom line.

Less stress on the Westpac share price

Westpac reported that total stressed assets on its balance sheet fell 15bps, with almost all industry segments improving.

The number of mortgagees that are behind payments by 90 days or more have also fell 6bps to 146bps.

Meanwhile, the bank’s core earnings grew 28% in the period, although it was up a more modest 3% if one-off items were excluded.

Improving outlook for ASX banks

The net impact of these tailwinds has bolstered Westpac’s CET1 ratio by 74bps to 11.9%. That’s above the banking regulator’s “unquestionably strong” benchmark.

There were no hints on dividends as this is only a quarterly update. The bank will report its half year results in May and will unveil its dividend decision then.

But don’t get too use to getting these quarterlies from Westpac. The COVID scare has passed in the bank’s view and it will return to past practice of not releasing quarterly earnings. This could be the biggest negative in the earnings announcement, in my view.

More reading

• Bank of Queensland (ASX:BOQ) shares hit a 52-week high today
• ASX 200 rises 0.7%, Redbubble sinks, BHP dividend jumps
• Here’s why the CBA (ASX:CBA) share price is underperforming today
• The NAB (ASX:NAB) share price is up after 47% profit growth in Q1
• ASX 200 up 0.5%: BHP impresses, NAB rises, Zip rockets

Motley Fool contributor Brendon Lau owns shares of Australia & New Zealand Banking Group Limited, Commonwealth Bank of Australia, National Australia Bank Limited, and Westpac Banking. Connect with me on Twitter @brenlau.

The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Westpac (ASX:WBC) share price on watch as it delivers $2bn quarterly profit result appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2Nt4cuC

The EBOS Group Ltd (ASX: EBO) share price is on watch this morning following the company’s half-year results release.

What could move the EBOS share price?

EBOS is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products

This morning, the Kiwi healthcare group provided an update on its performance to 31 December 2020 (1H 2021). EBOS reported “strong momentum” throughout the period with another record result highlighted by double-digit earnings growth.

The EBOS share price will be one to watch today after the company reported group revenue for the half was up 6.3% to $4.7 billion. Underlying earnings before interest and tax (EBIT) also jumped 11.5% to $147.8 million in a strong half for the company.

Statutory net profit after tax (NPAT) surged 13.7% higher to $92.9 million while underlying NPAT was up 14.2% to $94.3 million.

In good news for shareholders, underlying earnings per share (EPS) was up 12.7% to 57.8 cents in 1H 2021. The EBOS share price is also worth watching after the company increased its interim dividend by 13.3% to 42.5 cents.

Based on yesterday’s closing share price of $27.00, that represents a ~3.1% per annum dividend yield.

EBOS reported “very strong” performance across its healthcare and animal care business segments. Healthcare’s underlying EBIT jumped 11.2% with animal care EBIT up 25.6% for the half.

Operating cash flow surged 33.0% higher to $98.7 million, underpinned by strong group performance.

EBOS completed the acquisition of CH2’s vet distribution business for $9 million to boost its market position while also expanding its medical devices business with the recent Cryomed acquisition.

EBOS has continued to increase earnings across both its healthcare and animal care segments in recent years.

Foolish takeaway

The EBOS share price will be one to watch in early trade this morning after a record result for the Kiwi healthcare group. 

Double-digit earnings growth and broadly strong group performance, combined with a 13.3% interim dividend increase, make EBOS worth keeping an eye on today.

More reading

• Coles (ASX:COL) share price on watch following half year update
• Why the Hub24 (ASX:HUB) share price will be on watch today
• Why the Fletcher Building (ASX:FBU) share price could shoot higher today
• Bikeexchange (ASX:BEX) CEO Mark Watkins on the risks and opportunities ahead
• 3 outstanding ASX growth shares to buy today

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post EBOS (ASX:EBO) share price on watch after dividend surge appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3rYJ6TR

The Coles Group Ltd (ASX: COL) share price will be one to watch on Wednesday.

This follows the release of its half year results this morning.

How did Coles perform in the first half?

Coles was a positive performer during the first half of FY 2021 and delivered strong top and bottom line growth.

For the six months ended 31 December, the supermarket giant reported an 8% increase in revenue to $20,569 million. This comprised Supermarket sales of $17,800 million (up 7.3%), Liquor sales of $1,946 million (up 15.1%), and Express sales of $632 million (up 10.5%).

Management advised that this growth was driven by successful channel and trading plan execution and increased demand for in-home consumption associated with COVID-19.

Coles also revealed gross margin benefits associated with strategic sourcing and supply chain initiatives. These offset the impact of lower fuel commission income and increased administration expenses.

This led to the company’s earnings before interest and tax (EBIT) increasing 12.1% to $1,020 million. Management advised that Supermarkets EBIT increased 14.4%, Liquor EBIT jumped 36.8%, and Express EBIT rose 14.3%.

On the bottom line, Coles’ net profit increased 14.5% over the prior corresponding period to $560 million.

Also coming in strong was the company’s cash flow. Net cash flow before financing activities increased by $365 million to $1,229 million and its cash realisation ratio came in at 120%.

In light of its positive performance, the Coles board elected to increase its fully franked interim dividend by 10% to 33 cents per share.

How does this compare to expectations?

The company appears to have outperformed the market’s expectations during the half, which could bode well for the Coles share price today.

According to a note out of Goldman Sachs, it was expecting group sales of $20,585.9 million and underlying net profit after tax to $540.4 million.

The broker was, however, forecasting an interim dividend of 34 cents per share. So Coles fell a touch short on that.

Management commentary

Coles’ CEO, Steven Cain, was pleased with the half and the progress the company is making with its refreshed strategy.

He said: “We have now delivered the first 18 months of our refreshed strategy whilst ensuring that we support our team members, customers, suppliers and community partners through a volatile and unpredictable COVID-19 year.”

“In the half we have made significant progress in our Own Brand product development, online operations and supply chain automation. Whilst COVID-19 will continue to present challenges it will also continue to present opportunities for change. With a strong balance sheet and team, Coles is well placed to continue delivering on our vision of becoming the most trusted retailer in Australia and grow long-term shareholder value,” he added.

Outlook

Coles provided a very cautious outlook statement, which could potentially weigh on the Coles share price today. It notes that it is about to cycle very strong sales growth from a year earlier.

Management explained: “Depending on COVID-19, vaccine roll out and efficacy, and other factors, sales in the supermarket sector may moderate significantly or even decline in the second half of FY21 and into FY22. Coles will be cycling elevated sales from COVID-19 in Supermarkets late in the third quarter, for the remainder of the second half, and most of FY22.”

The company also provided an update on the performance of its businesses since the end of the half.

It advised that Supermarkets comparable sales growth has continued to moderate and in the first six weeks of the third quarter was 3.3%.

As for Liquor, its sales remained elevated for the first six weeks of the third quarter with comparable sales growth of 12.5%. Management notes that the business is currently cycling the impact of the bushfires in the prior corresponding period.

What else?

Another thing that could potentially weigh on the Coles share price today was its gross operating capital expenditure guidance. Management advised that it has increased its guidance to approximately $1.1 billion from $1 billion. Though, this is for a good reason.

It explained that the additional funds will be used to invest in opportunities that have arisen out of COVID-19 including Coles Local acceleration, ecommerce, and operational efficiencies in stores such as the customer packing benches.

More reading

• 5 things to watch on the ASX 200 on Wednesday
• The latest ASX shares upgraded by brokers to “buy” during the reporting season
• ASX 200 Weekly Wrap: ASX cools on earnings reality check
• 5 things to watch on the ASX 200 next week
• How big will the ASX bank dividends be in 2021 and beyond?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of COLESGROUP DEF SET. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Coles (ASX:COL) share price on watch following half year update appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3jW5ri1

Hub24 Ltd (ASX: HUB) shares will be on watch this morning after the company updated the market late yesterday about its proposed takeover offer to Easton Investments Ltd (ASX: EAS). At Tuesday’s market close, the Hub24 share price finished the day 2% lower at $26.32.

Hub24’s tabled offer

The Hub24 share price could be on the move today after the company advised its takeover offer will expire soon. Hub24 updated the ASX about its intentions in the final hour of trade yesterday.

According to its release, Hub24 advised that it will not be extending its off-market takeover offer past 7:00 pm on 22 February 2021.

Last month, the company put forward its offer to Easton shareholders in a bid to acquire one out of every three ordinary shares. The cash consideration offered to Easton shareholders stood at $1.20 per Easton share.

Easton directors unanimously urged its shareholders to accept the takeover offer from Hub24, in the absence of a superior offer.

It’s worth noting that Hub24 currently holds a 29.3% interest in Easton. Each of Easton’s directors accepted the takeover offer, which represented 3,411,206 shares or 9.1% of all Easton shares.

Quick take on Hub24

Established in 2007, Hub24 is a fintech company that provides investment and superannuation portfolio administration services. The group’s platform offers a range of investment management options, including transaction and reporting solutions. These allow advisors to efficiently manage their clients’ wealth portfolios and provide value-added services. 

Hub24 share price snapshot

Over the last 12 months, the Hub24 share price has accelerated, delivering gains of more than 140%. During March 2020, Hub24 shares fell to a 52-week low of $5.98 before zooming higher. Just last week, the company’s shares reached an all-time high of $27.80 and are now within striking distance of breaking that new record again.

Based on the current Hub24 share price, the company commands a market capitalisation of around $1.76 billion.

More reading

• What’s with the Hub24 (ASX:HUB) share price today?
• Why BHP, Estia Health, HUB24, & South32 shares are dropping lower
• 5 things to watch on the ASX 200 on Friday
• The latest ASX stocks to be upgraded by brokers to “buy” today
• 5 things to watch on the ASX 200 on Wednesday

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Hub24 Ltd. The Motley Fool Australia has recommended Hub24 Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Hub24 (ASX:HUB) share price will be on watch today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3qrcEJj